Literature DB >> 22495670

Sphere formation and self-renewal capacity of melanoma cells is affected by the microenvironment.

Malgorzata Sztiller-Sikorska1, Kamila Koprowska, Justyna Jakubowska, Izabela Zalesna, Marta Stasiak, Markus Duechler, Malgorzata Ewa Czyz.   

Abstract

Melanomas contain subsets of cancer stem-like cells with tumor-initiating capacity. The frequency of these cells in the tumor is still a topic of debate. We investigated the phenotypic plasticity of cancer cells grown as melanospheres to elucidate the influence of the microenvironment on some features of melanoma stem-like cells. Cells from surgical specimens of nodular melanoma were grown as anchorage-independent melanospheres in a stem cell medium and as adherent monolayer cultures in the presence of serum. Proliferation and viability were measured by cell counting and an acid phosphatase assay; surface marker expression was evaluated by flow cytometry, and the clonogenic potential of single cells was assessed by growth in soft agar. Patient-derived melanoma cells could be maintained in cell culture for more than 16 months when grown as melanospheres. In the presence of serum, melanospheres completely changed their growth characteristics and formed adherent monolayers. The transition from melanospheres to monolayers was accompanied by an apparent loss of clonogenic potential, an increased proliferation rate, and altered expressions of cell surface markers ABCB5, CD133, and CD49f. These changes, however, were reversible. Compared with adherent monolayer cultures, melanospheres are enriched in cells with clonogenic potential, reflecting the self-renewing capacity of cancer stem-like cells. This clonogenic potential can be lost and regained depending on the growth conditions. Our results demonstrate how easily melanoma cells change their function upon exposure to external stimuli and suggest that the frequency of melanoma stem-like cells strongly depends on the microenvironment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495670     DOI: 10.1097/CMR.0b013e3283531317

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  25 in total

1.  Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells.

Authors:  Mariusz L Hartman; Michal Rozanski; Marta Osrodek; Izabela Zalesna; Malgorzata Czyz
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

2.  NME1 Drives Expansion of Melanoma Cells with Enhanced Tumor Growth and Metastatic Properties.

Authors:  Ying Wang; M Kathryn Leonard; Devin E Snyder; Matthew L Fisher; Richard L Eckert; David M Kaetzel
Journal:  Mol Cancer Res       Date:  2019-05-23       Impact factor: 5.852

3.  Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.

Authors:  Allison R Larson; Chung-Wei Lee; Cecilia Lezcano; Qian Zhan; John Huang; Andrew H Fischer; George F Murphy
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

4.  Phenotypic diversity of patient-derived melanoma populations in stem cell medium.

Authors:  Malgorzata Sztiller-Sikorska; Mariusz L Hartman; Beata Talar; Justyna Jakubowska; Izabela Zalesna; Malgorzata Czyz
Journal:  Lab Invest       Date:  2015-04-13       Impact factor: 5.662

5.  Differential remodeling of extracellular matrices by breast cancer initiating cells.

Authors:  Anju M Raja; Shuoyu Xu; Shuangmu Zhuo; Dean C S Tai; Wanxin Sun; Peter T C So; Roy E Welsch; Chien-Shing Chen; Hanry Yu
Journal:  J Biophotonics       Date:  2015-01-19       Impact factor: 3.207

6.  Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells.

Authors:  Germana Rappa; Javier Mercapide; Fabio Anzanello; Thuc T Le; Mary G Johlfs; Ronald R Fiscus; Michaela Wilsch-Bräuninger; Denis Corbeil; Aurelio Lorico
Journal:  Exp Cell Res       Date:  2013-01-12       Impact factor: 3.905

7.  MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.

Authors:  Mariusz L Hartman; Beata Talar; Anna Gajos-Michniewicz; Malgorzata Czyz
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

8.  Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.

Authors:  Malgorzata Czyz; Kamila Koprowska; Malgorzata Sztiller-Sikorska
Journal:  Cancer Biol Ther       Date:  2012-11-28       Impact factor: 4.742

9.  Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.

Authors:  Mariusz L Hartman; Beata Talar; Muhammad Zaeem Noman; Anna Gajos-Michniewicz; Salem Chouaib; Malgorzata Czyz
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

10.  Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells.

Authors:  Malgorzata Sztiller-Sikorska; Kamila Koprowska; Kinga Majchrzak; Mariusz Hartman; Malgorzata Czyz
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.